Skin Substitutes and the 2026 CMS Rule: FAQ for Wound Care Providers

The 2026 CMS skin substitutes rule reshapes coverage, pricing, and documentation expectations. Here are the questions we hear most.

What changes under the 2026 CMS rule?

CMS is consolidating payment methodology and tightening documentation requirements for skin substitute applications. See our full analysis in Skin substitutes after the 2026 CMS rule.

Which wounds still qualify for coverage?

Coverage remains focused on chronic wounds — primarily diabetic foot ulcers and venous leg ulcers — that have failed standard care for a documented period. Etiology, duration, and conservative care history must be in the chart before the first application.

What documentation do payers expect for each application?

Expect scrutiny of medical necessity, prior conservative treatment, wound measurements at each visit, product used, size applied vs. size wasted, and response to prior applications.

How do I prove failed conservative care?

You need a documented trial period with offloading, debridement, moisture balance, and infection control. The AI-powered EMR for wound care structures this history so it's retrievable at claim time.

How do I track healing to justify continued applications?

Use the healing dashboard to show percent area reduction over time. Payers increasingly expect trajectory evidence, not just serial measurements.

What happens if a claim is audited?

WISER claims and compliance surfaces LCD gaps before signature and packages the supporting documentation for audit response.